Quintiles, London Genetics ally to enhance drug discovery and development through pharmacogenetics

Alliance combines world-class expertise and global infrastructure to support biopharma in the development of personalized medicine

02-Dec-2010 - Quintiles and London Genetics announced a strategic alliance to offer the biopharmaceutical industry pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed. Under the non-exclusive alliance, Quintiles and London Genetics will collaborate to help biopharma ...

London Genetics and Astrimmune to collaborate on cancer vaccine

17-Nov-2010 - London Genetics Limited and Astrimmune announced that they have entered into a collaboration to plan a biomarker identification programme. The plan, for Astrimmune’s early-stage pancreatic cancer vaccine candidate, will be used in applications for further funding of its development. Financial ...

London Genetics expands its senior advisory team

23-Jul-2010 - London Genetics Limited announced that it has augmented the strength of its team with the appointment of two senior advisers, Professors Stephen DeCherney and Munir Pirmohamed. Stephen DeCherney MD, MPH, is Professor of Medicine at the University of Carolina, and was previously President, Global ...

New Appointments at London Genetics to Drive Strategy Forward

21-Sep-2009 - London Genetics Limited announced several appointments to its Board and management team. The new appointments, which include Dr Barrie Ward as Chairman, will drive the next phase of the company’s growth as the importance of pharmacogenetics in drug development increases. They bring important ...

GenoLogics Announces Partnership with London Genetics

18-Oct-2007 - GenoLogics announced it will work closely with London Genetics Ltd., a commercial company whose purpose is to facilitate and manage partnerships between the health care industry and centers of biomedical excellence in London, to identify opportunities for collaboration. GenoLogics will help ...